Emerging links between type 2 diabetes and Alzheimer's disease

被引:89
|
作者
Sridhar, Gumpeny R. [1 ]
Lakshmi, Gumpeny [1 ]
Nagamani, Gumpeny [1 ]
机构
[1] Andhra Med Coll, Endocrine & Diabet Ctr, Dept Obstet & Gynecol, Visakhapatnam 530002, Andhra Pradesh, India
来源
WORLD JOURNAL OF DIABETES | 2015年 / 6卷 / 05期
关键词
Cognition; Insulin resistance; Insulin; Butyrylcholinesterase; Dementia;
D O I
10.4239/wjd.v6.i5.744
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes mellitus and Alzheimer's disease are both associated with increasing age, and each increases the risk of development of the other. Epidemiological, clinical, biochemical and imaging studies have shown that elevated glucose levels and diabetes are associated with cognitive dysfunction, the most prevalent cause of which is Alzheimer's disease. Cross sectional studies have clearly shown such an association, whereas longitudinal studies are equivocal, reflecting the many complex ways in which the two interact. Despite the dichotomy, common risk and etiological factors (obesity, dyslipidemia, insulin resistance, and sedentary habits) are recognized; correction of these by lifestyle changes and pharmacological agents can be expected to prevent or retard the progression of both diseases. Common pathogenic factors in both conditions span a broad sweep including chronic hyperglycemia per se, hyperinsulinemia, insulin resistance, acute hypoglycemic episodes, especially in the elderly, microvascular disease, fibrillar deposits (in brain in Alzheimer's disease and in pancreas in type 2 diabetes), altered insulin processing, inflammation, obesity, dyslipidemia, altered levels of insulin like growth factor and occurrence of variant forms of the protein butyrylcholinesterase. Of interest not only do lifestyle measures have a protective effect against the development of cognitive impairment due to Alzheimer's disease, but so do some of the pharmacological agents used in the treatment of diabetes such as insulin (especially when delivered intranasally), metformin, peroxisome proliferator-activated receptors. agonists, glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Diabetes must be recognized as a risk for development of Alzheimer's disease; clinicians must ensure preventive care be given to control and postpone both conditions, and to identify cognitive impairment early to manage it appropriately. (C) The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:744 / 751
页数:8
相关论文
共 50 条
  • [1] An update on potential links between type 2 diabetes mellitus and Alzheimer's disease
    De Sousa, Ricardo Augusto Leoni
    Harmer, Alison R.
    Freitas, Daniel Almeida
    Mendonca, Vanessa Amaral
    Lacerda, Ana Cristina Rodrigues
    Leite, Hercules Ribeiro
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (08) : 6347 - 6356
  • [2] Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer's Disease
    McIntosh, Elissa C.
    Nation, Daniel A.
    DIABETES CARE, 2019, 42 (05) : 972 - 979
  • [3] An update on potential links between type 2 diabetes mellitus and Alzheimer’s disease
    Ricardo Augusto Leoni De Sousa
    Alison R. Harmer
    Daniel Almeida Freitas
    Vanessa Amaral Mendonça
    Ana Cristina Rodrigues Lacerda
    Hércules Ribeiro Leite
    Molecular Biology Reports, 2020, 47 : 6347 - 6356
  • [4] Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review
    Mittal, Khyati
    Katare, Deepshikha Pande
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2016, 10 (02) : S144 - S149
  • [5] Links between Alzheimer's disease and diabetes
    Sun, Miao-Kun
    Alkon, Daniel L.
    DRUGS OF TODAY, 2006, 42 (07) : 481 - 489
  • [6] Metabolic links between diabetes and Alzheimer's disease
    Maher, Pamela A.
    Schubert, David R.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (05) : 617 - 630
  • [7] Emerging links between cell competition and Alzheimer's disease
    Coelho, Dina S.
    Moreno, Eduardo
    JOURNAL OF CELL SCIENCE, 2019, 132 (13)
  • [8] Type 2 Diabetes Mellitus and Alzheimer's Disease: A Review of the Potential Links
    Pakdin, Majid
    Toutounchian, Samaneh
    Namazi, Sina
    Arabpour, Zahra
    Pouladi, Amirreza
    Afsahi, Sahar
    Poudineh, Mohadeseh
    Nasab, Mohammad Mehdi Mousavi
    Yaghoobpoor, Shirin
    Deravi, Niloofar
    CURRENT DIABETES REVIEWS, 2022, 18 (08) : 14 - 27
  • [9] Alzheimer's disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
    Rojas, Milagros
    Chavez-Castillo, Mervin
    Bautista, Jordan
    Ortega, Angel
    Nava, Manuel
    Salazar, Juan
    Diaz-Camargo, Edgar
    Medina, Oscar
    Rojas-Quintero, Joselyn
    Bermudez, Valmore
    WORLD JOURNAL OF DIABETES, 2021, 12 (06)
  • [10] Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes
    Michailidis, Michalis
    Moraitou, Despina
    Tata, Despina A.
    Kalinderi, Kallirhoe
    Papamitsou, Theodora
    Papaliagkas, Vasileios
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)